MILLIGAN DAVID V 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
MILLIGAN DAVID V
Director
Transactions
- Award
Stock Option (Right to buy)
2022-06-16+9,470→ 9,470 totalExercise: $65.06Exp: 2025-06-16→ Common Stock (9,470 underlying)
Footnotes (1)
- [F1]The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.